Medical Laboratory Equipment Switzerland: 6.5–9.5× EBITDA, 344 Firms (2026)

1.0Market Snapshot

344: Enterprises manufacturing measuring, testing and laboratory instruments (NOGA 26.51) in 2024, plus 113 manufacturing electromedical equipment (NOGA 26.60) (BFS STATENT). No official class isolates medical laboratory equipment; 26.51 also includes industrial measuring instruments.
18,530: People employed in measuring, testing and laboratory instruments (NOGA 26.51) in 2024, up 21.6% since 2011; a further 13,171 work in electromedical equipment (NOGA 26.60), 3,540 of them in the canton of Zug, where Roche Diagnostics International is registered (BFS STATENT).
+2.8%: Employment growth 2023–2024 in measuring, testing and laboratory instruments (18,022 to 18,530; BFS STATENT). Employment in electromedical equipment fell 3.8% in the same year (13,688 to 13,171).

According to Val Index analysis of Swiss commercial-register and federal data (2026), Switzerland counts 344 medical laboratory equipment companies — Enterprises manufacturing measuring, testing and laboratory instruments (NOGA 26.51) in 2024, plus 113 manufacturing electromedical equipment (NOGA 26.60) (BFS STATENT). No official class isolates medical laboratory equipment; 26.51 also includes industrial measuring instruments..

2.0Industry Overview

Market Scope

Switzerland is home to some of the world's largest makers of laboratory and diagnostic equipment. Roche's Diagnostics Division, whose global business is run from Rotkreuz in the canton of Zug, had sales of CHF 13.8 billion in 2025. Tecan in Männedorf (CHF 882.5 million) and Hamilton in Bonaduz lead in laboratory automation and liquid handling; Mettler-Toledo, run from Greifensee and Columbus (Ohio), makes laboratory balances and analytical instruments with net sales of USD 4.0 billion; Metrohm in Herisau makes analytical instruments for chemical analysis. Around them sits a layer of specialised SMEs in diagnostics, pipetting, bioreactors and instrument components.

3.0Industry Health Check (SWOT)

Internal factors

Strengths4

Global leaders headquartered or run from Switzerland: Roche Diagnostics, Tecan, Mettler-Toledo, Hamilton, Metrohm

Weaknesses4

Dependence on a few very large groups for employment and supplier demand

External factors

Opportunities4

Laboratory automation and molecular diagnostics — Roche's pathology and molecular solutions grew in 2025

Threats4

Health-system pricing reforms, such as China's, which cut Roche's Asia-Pacific diagnostics sales by 12% in 2025

Sector Outlook

DefensiveBalancedGrowth

4.0Key Trends

Diagnostics grows slowly in francs

Roche's Diagnostics Division grew sales 2% at constant exchange rates to CHF 13.8 billion in 2025, a 3% fall in francs. Demand for pathology and molecular solutions more than offset healthcare pricing reforms in China: sales rose 6% in Europe, the Middle East and Africa, 9% in North America and 11% in Latin America, but fell 12% in Asia-Pacific.

Tecan rewires

CHF 882.5 million

Tecan's 2025 sales fell to CHF 882.5 million (2024: CHF 934.3 million), down 1.6% in local currencies, with an adjusted EBITDA margin of 16.1%. It booked a CHF 139.5 million impairment on restructuring less profitable product lines in its partnering business and launched "Rewired", aiming for CHF 1 billion of sales and a 20% adjusted EBITDA margin by 2028.

Fewer, larger electromedical manufacturers

21.6%

STATENT shows the number of electromedical equipment enterprises falling from 157 in 2011 to 113 in 2024 while employment rose from 10,543 to 13,171 — average size nearly doubled to 111 full-time equivalents. In measuring, testing and laboratory instruments the number of firms stayed around 340 and employment grew 21.6%.

The laboratories are consolidating

CHF 114 million

Swiss medical laboratories — the main domestic customers — are merging into larger networks. Galenica bought Labor Team, the fourth-largest provider in the Swiss laboratory market with well over seven million analyses a year and combined net sales of CHF 114 million in 2024. Larger laboratory groups buy more automation and negotiate harder on instrument and reagent prices.

Steady demand for laboratory instruments

Mettler-Toledo raised 2025 net sales 4% to USD 4.026 billion (3% in local currencies); local-currency sales grew 5% in the Americas, 1% in Europe and 2% in Asia and the rest of the world. Laboratory balances, analytical instruments and service remain a stable business compared with diagnostics, which depends on health-system budgets.

5.0Cost Structure Benchmark

25%

28%

12%

14%

Materials and components25%: optics, electronics, precision parts
Production and service personnel28%
Research and development12%
Sales, marketing and distribution14%
Administration, quality assurance and regulatory7%
EBITDA margin14%

Indicative split, not measured. It is aligned with published margins: Tecan reported an adjusted EBITDA margin of 16.1% for 2025, a benchmark for a scaled listed player. Diagnostics companies with a large installed base of instruments earn a higher share from consumables and reagents; component makers and small instrument builders work with lower margins.

6.0Top Medical Laboratory Equipment Companies in Switzerland

Name	Location	Key Facts
Roche DiagnosticsCHE-104.722.452	Risch/Rotkreuz ZG	Roche Diagnostics International AG, registered in Risch (Rotkreuz) ZG: global headquarters of Roche's Diagnostics Division, the world's largest in-vitro diagnostics business. 2025 division sales CHF 13.8 billion (+2% at constant exchange rates, −3% in francs), with growth in pathology and molecular diagnostics.
Tecan GroupCHE-107.957.514	Männedorf ZH	Tecan Group AG, Männedorf ZH: SIX-listed maker of laboratory automation and liquid-handling systems, about 3,000 employees worldwide. 2025 sales CHF 882.5 million (−1.6% in local currencies), adjusted EBITDA margin 16.1%; "Rewired" programme targets CHF 1 billion of sales and a 20% margin by 2028.
Mettler-ToledoCHE-105.929.582	Greifensee ZH	Mettler-Toledo GmbH, Greifensee ZH: Swiss operating company of Mettler-Toledo International (NYSE), maker of laboratory balances, pipettes and analytical instruments. 2025 group net sales USD 4.026 billion (+4%).
HamiltonCHE-105.945.836	Bonaduz GR	Hamilton AG, Bonaduz GR: company in laboratory automation, medical technology and sensors, headquartered in Bonaduz.
MetrohmCHE-105.928.996	Herisau AR	Metrohm AG, Herisau AR: maker of instruments for chemical analysis (titration, ion chromatography, spectroscopy), founded in 1943 and fully owned by the Metrohm Foundation since the founder created it in 1982. Active in more than 80 countries through more than 37 subsidiaries; most instruments are developed and built in Herisau.
BÜHLMANN LaboratoriesCHE-107.878.027	Schönenbuch BL	BÜHLMANN Laboratories AG, Schönenbuch BL: Swiss developer and manufacturer of in-vitro diagnostic assays.

Roche Diagnostics

CHE-104.722.452

Risch/Rotkreuz ZG

Roche Diagnostics International AG, registered in Risch (Rotkreuz) ZG: global headquarters of Roche's Diagnostics Division, the world's largest in-vitro diagnostics business. 2025 division sales CHF 13.8 billion (+2% at constant exchange rates, −3% in francs), with growth in pathology and molecular diagnostics.

Tecan Group

CHE-107.957.514

Männedorf ZH

Tecan Group AG, Männedorf ZH: SIX-listed maker of laboratory automation and liquid-handling systems, about 3,000 employees worldwide. 2025 sales CHF 882.5 million (−1.6% in local currencies), adjusted EBITDA margin 16.1%; "Rewired" programme targets CHF 1 billion of sales and a 20% margin by 2028.

Mettler-Toledo

CHE-105.929.582

Greifensee ZH

Mettler-Toledo GmbH, Greifensee ZH: Swiss operating company of Mettler-Toledo International (NYSE), maker of laboratory balances, pipettes and analytical instruments. 2025 group net sales USD 4.026 billion (+4%).

Hamilton

CHE-105.945.836

Bonaduz GR

Hamilton AG, Bonaduz GR: company in laboratory automation, medical technology and sensors, headquartered in Bonaduz.

Metrohm

CHE-105.928.996

Herisau AR

Metrohm AG, Herisau AR: maker of instruments for chemical analysis (titration, ion chromatography, spectroscopy), founded in 1943 and fully owned by the Metrohm Foundation since the founder created it in 1982. Active in more than 80 countries through more than 37 subsidiaries; most instruments are developed and built in Herisau.

BÜHLMANN Laboratories

CHE-107.878.027

Schönenbuch BL

BÜHLMANN Laboratories AG, Schönenbuch BL: Swiss developer and manufacturer of in-vitro diagnostic assays.

Companies are listed when they are confirmed in the commercial register, have a significant Swiss presence in this niche and at least one sourced fact.

7.0Succession & M&A Context

Global groups at the top, specialised family firms underneath

344: enterprises making measuring, testing and laboratory instruments in 2024 (BFS STATENT, NOGA 26.51)
−28%: electromedical equipment enterprises 2011–2024: 157 to 113 (BFS STATENT)
CHF 13.8B: Roche Diagnostics Division sales 2025 (+2% at constant exchange rates)
6.5–9.5×: EBITDA deal multiples for medical laboratory equipment (ValIndex multiples table)

The large players are listed groups (Roche, Tecan, Mettler-Toledo) or foundation-owned (Metrohm, whose founder transferred it to the Metrohm Foundation in 1982 — a common Swiss answer to succession). Below them are some 340 instrument makers averaging 50 full-time equivalents and a shrinking group of electromedical manufacturers. Succession in this segment usually ends in a sale to a strategic buyer that wants the technology, the regulatory approvals and the installed base, or to a larger Swiss or European instrument group; foundations and family holdings are the alternative for owners who want to keep the company independent. The STATENT data show consolidation already under way in electromedical equipment, where the number of enterprises fell by 28% between 2011 and 2024. ValIndex's multiples table puts transactions at 6.5–9.5× EBITDA and statutory valuations at 5.0–7.0× EBITDA; recurring revenue from consumables and service and approved diagnostic products command the upper end.

Market Pulse

Unlock full Medical Laboratory Equipment intelligence

Market trends, cost structure, key players, succession analysis and regional clusters for Medical Laboratory Equipment — free with Market Pulse, our monthly letter on Swiss deals.

Includes one letter a month on Swiss deals. Unsubscribe anytime.

Valuation Snapshot

Medical Laboratory Equipment business valuation in Switzerland

Statutory Multiple (EBITDA): 5.0 - 7.0×
Deal Multiple (EBITDA): 6.5 - 9.5×
Market Trend: Rising

Indicative ranges based on market research. Actual multiples vary by company size, growth, and market conditions.

8.0Regional Clusters

Zurich

88 instrument makers and 17 electromedical manufacturers with 10,165 employees (BFS STATENT 2024), the largest cluster. Tecan (Männedorf) and Mettler-Toledo (Greifensee) are based here.

Zug and Central Switzerland

ZGLUSZNWOWUR

5,076 employees, 3,540 of them in electromedical equipment in Zug, where Roche Diagnostics International is registered (Rotkreuz). Lucerne adds 741 instrument employees.

Espace Mittelland

BEFRSONEJU

4,994 employees — 2,006 in instruments and 2,988 in electromedical equipment, led by Bern (1,730) and Fribourg (940). Neuchâtel contributes micro-technology suppliers.

Basel and Aargau

BSBLAG

4,379 employees, 3,672 of them in instruments — Basel-Landschaft alone 2,191. BÜHLMANN Laboratories (Schönenbuch) is based here, close to the Basel pharma cluster.

Eastern Switzerland and Ticino

SGARGRTGSHGLTI

4,144 employees. Metrohm (Herisau AR, 779 instrument employees in the canton) and Hamilton (Bonaduz GR, 843 instrument employees in the canton) anchor the region.

Lake Geneva

VDGEVS

2,937 employees, 1,878 of them in electromedical equipment in Vaud. Pipette and dispenser makers such as Socorex (Ecublens) are based here.

Sources

BFS STATENT — institutional units, employees and FTE by NOGA type and canton, 2011–2024 (NOGA 265100 measuring, testing and laboratory instruments; 266000 electromedical equipment)Roche — 2025 results (29 January 2026): Diagnostics Division sales CHF 13.8bn, +2% CER Tecan — 2025 results and "Rewired" programme (16 March 2026)Mettler-Toledo International — fourth quarter and full-year 2025 results (5 February 2026)Galenica — Annual Report 2025: Labor Team, new in the Galenica network Galenica — Galenica to enter the diagnostics business by acquiring Labor Team (Labor Team 2024 net sales CHF 114m)Metrohm — About us (founded 1943, owned by the Metrohm Foundation since 1982)Canton of Graubünden — Hamilton Bonaduz AG company profile Zefix — Swiss Central Business Name Index (register entries of all key players)

Alain Walder, M.A. HSG · ValIndex|Data as of 2026-09|9 sources cited

9.0Frequently Asked Questions

▶How much is a medical laboratory equipment company worth in Switzerland?

ValIndex's multiples table puts Swiss medical laboratory equipment companies at 6.5–9.5× EBITDA in transactions and 5.0–7.0× EBITDA on statutory valuations. Companies with a large installed base that generates recurring revenue from consumables, reagents and service, and with approved diagnostic products, reach the upper end; component suppliers and project-based instrument builders the lower end. Tecan, a scaled listed player, reported an adjusted EBITDA margin of 16.1% for 2025.

▶What factors determine the value of a laboratory equipment company?

Buyers look at: (1) the installed base and the share of recurring revenue from consumables, reagents and service; (2) regulatory approvals — CE marking under the EU IVDR for diagnostics; (3) proprietary technology and patents; (4) dependence on a few large OEM customers; (5) currency exposure, since most sales are abroad. Key engineers and the founder's role in product development are frequent diligence points.

▶How many laboratory and diagnostic equipment companies are there in Switzerland?

No official statistic counts medical laboratory equipment makers as such. BFS STATENT counted 344 enterprises making measuring, testing and laboratory instruments (NOGA 26.51) with 18,530 employees in 2024, and 113 making electromedical equipment (NOGA 26.60) with 13,171 employees. The first class also includes industrial measuring instruments. Zurich has the most enterprises in both classes.

▶How does succession work for Swiss laboratory equipment companies?

The large players are listed (Roche, Tecan, Mettler-Toledo) or foundation-owned — Metrohm's founder transferred the company to the Metrohm Foundation in 1982. Among smaller makers, succession usually ends in a sale to a strategic buyer that wants the technology, approvals and installed base. Consolidation is visible in the data: electromedical equipment enterprises fell from 157 in 2011 to 113 in 2024 while employment rose.

▶What are the key trends in Swiss laboratory and diagnostic equipment?

Five trends: (1) Roche's diagnostics sales grew 2% at constant rates in 2025 to CHF 13.8 billion, held back by pricing reforms in China; (2) Tecan's sales fell to CHF 882.5 million and it launched a restructuring programme; (3) electromedical manufacturers are fewer but larger (113 enterprises averaging 111 full-time equivalents); (4) medical laboratories are consolidating — Galenica bought Labor Team, the fourth-largest; (5) laboratory instruments remain steady — Mettler-Toledo grew 3% in local currencies.

▶What are the main risks when buying a laboratory equipment company?

The main risks are: (1) health-system pricing decisions, as China's reforms showed; (2) weaker biopharma and research budgets; (3) regulatory cost under the EU IVDR; (4) the strong franc; (5) concentration on a few OEM customers or distributors. Due diligence should check the installed base, the recurring revenue share, regulatory status of each product and customer concentration.

▶What is the typical cost structure of a Swiss laboratory equipment company?

An indicative split for a Swiss laboratory equipment company: materials and components around 25% of revenue, production and service personnel 28%, research and development 12%, sales, marketing and distribution 14%, administration, quality assurance and regulatory 7%, leaving an EBITDA margin of around 14%. The split is indicative, aligned with Tecan's published 2025 adjusted EBITDA margin of 16.1%; component makers and small instrument builders work with lower margins.

▶Where are the main laboratory equipment clusters in Switzerland?

Zurich is the largest cluster with 105 enterprises and 10,165 employees in the two classes, home to Tecan and Mettler-Toledo. Zug and Central Switzerland follow with 5,076 employees, most of them at Roche Diagnostics in Rotkreuz. The Espace Mittelland has 4,994 employees, Basel and Aargau 4,379, Eastern Switzerland 4,144 (Metrohm, Hamilton) and the Lake Geneva region 2,937 (BFS STATENT 2024; canton figures sum to 31,695 because of rounding and confidentiality).

Medical Laboratory Equipment